Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova Biomedical develops and commercializes analytical instruments—primarily blood testing analyzers—for clinical settings such as hospitals and critical care units as well as for biopharmaceutical process development. Their products are widely used globally with over half of U.S. hospitals utilizing their critical care products. The company has a strong reputation for innovation in whole blood biosensors and rapid point-of-care diagnostics. As of March 2025, it was acquired by Advanced Instruments but continues to operate under its own name with combined global reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Biomedical.